Yale Coalition Project
•
2 likes•440 views
This document summarizes a medical device company that provides innovative surgical products including wound closure, hernia repair, and surgical devices. The company's mission is to ethically collaborate with medical professionals to enhance patient quality of life and improve outcomes for customers and shareholders. It focuses on improving healthcare through high performance, globalization, customer focus, and innovation. The company has a history of pioneering surgical products and becoming a leader through acquisitions, product upgrades, and collaborating with prestigious hospitals. It provides summaries of its wound closure products, product enhancements, innovations, and processes for successful conversion to new products.
Report
Share
Report
Share
Recommended
Bilcare GCS Packaging and Labeling Capabilities
Bilcare GCS offers formulation development, clinical manufacturing, packaging, and labeling services to pharmaceutical and consumer healthcare clients. They have experienced scientists and state-of-the-art facilities to efficiently develop innovative formulations. Bilcare aims to help clients overcome challenges and accelerate time to market. Their integrated services allow seamless product development from formulation through clinical trials and commercialization. Bilcare has extensive experience producing various dosage forms and packaging configurations for clinical trials.
Powerful & Cost Effective Solution For Contract Packaging
This document summarizes the services and capabilities of Outlook Group, a contract packaging company. In 3 sentences: Outlook Group has over 40 years of experience in packaging and 350 employees across a 450,000 square foot facility. They provide various packaging solutions including labels, folding cartons, flexible packaging, and contract packaging. Outlook Group boasts quality certifications and uses cross-functional expert teams to provide original, customized packaging solutions that meet clients' specific needs.
Bilcare slideshare
Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. We endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.
Marketing II: Indu Isaacs
The document describes the services of a contract development and manufacturing organization called Lowell and Andover. It outlines their capabilities in formulation development, analytical development, manufacturing, and regulatory experience assisting clients from discovery through post-approval. Their goal is meeting expectations for timelines and producing consistent, stable dosage forms to help clients advance products at the speed of science.
AVK_Corporate_brochure
The document provides an overview of the AVK Group of Companies, which manufactures valves, hydrants, fittings and accessories. It discusses the company's mission of being the preferred supplier through a focus on quality, innovation, reliability, sustainability and customer service. It outlines the company's global leadership position through its large international network of over 65 subsidiaries worldwide, and commitment to local markets through customized local solutions. It also discusses the company's production processes, quality management systems, sales and marketing network, and focus on corporate social responsibility.
Nice neotech profile
Nice Neotech Medical Systems is a medical equipment company established in 1997 in India. It has over 4000 satisfied customers and 125 skilled employees. The company produces a range of neonatal intensive care unit products like incubators, radiant warmers, and respiratory humidifiers. Nice Neotech strives for innovation, high quality, and customer satisfaction in bringing affordable medical technology to the Indian and international markets.
Medical Packaging Experts
We at Buckell Plastic Co., Inc., understand the complex packaging requirements of the medical industry.
Hernia Repair Devices and Consumables Market is Expected to Reach $6.1 Billio...
Hernia Repair Devices and Consumables Market is Expected to Reach $6.1 Billio...Omkar Gaikwad (Digital Om)
Hernia Repair Devices and Consumables Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $6.1 Billion by 2020, registering a CAGR of 6.5% during the period 2014-2020. Consumables (mesh, staple and tacks) segment would continue to be the leading segment of the global hernia repair market in 2020, largely due to the augmentation in hernia cases, recurrence rate and emergence of advanced meshes.
View Detail Summary of this report: https://www.alliedmarketresearch.com/hernia-repair-devices-marketRecommended
Bilcare GCS Packaging and Labeling Capabilities
Bilcare GCS offers formulation development, clinical manufacturing, packaging, and labeling services to pharmaceutical and consumer healthcare clients. They have experienced scientists and state-of-the-art facilities to efficiently develop innovative formulations. Bilcare aims to help clients overcome challenges and accelerate time to market. Their integrated services allow seamless product development from formulation through clinical trials and commercialization. Bilcare has extensive experience producing various dosage forms and packaging configurations for clinical trials.
Powerful & Cost Effective Solution For Contract Packaging
This document summarizes the services and capabilities of Outlook Group, a contract packaging company. In 3 sentences: Outlook Group has over 40 years of experience in packaging and 350 employees across a 450,000 square foot facility. They provide various packaging solutions including labels, folding cartons, flexible packaging, and contract packaging. Outlook Group boasts quality certifications and uses cross-functional expert teams to provide original, customized packaging solutions that meet clients' specific needs.
Bilcare slideshare
Bilcare is a global leader and an innovation-led packaging solutions provider that partners with the pharmaceutical industry to improve patient healthcare outcomes. We endeavor to deliver effective and affordable solutions that enhance the speed and quality of drug discovery and help build and protect brands by ensuring the delivery of genuine medicines to patients.
Marketing II: Indu Isaacs
The document describes the services of a contract development and manufacturing organization called Lowell and Andover. It outlines their capabilities in formulation development, analytical development, manufacturing, and regulatory experience assisting clients from discovery through post-approval. Their goal is meeting expectations for timelines and producing consistent, stable dosage forms to help clients advance products at the speed of science.
AVK_Corporate_brochure
The document provides an overview of the AVK Group of Companies, which manufactures valves, hydrants, fittings and accessories. It discusses the company's mission of being the preferred supplier through a focus on quality, innovation, reliability, sustainability and customer service. It outlines the company's global leadership position through its large international network of over 65 subsidiaries worldwide, and commitment to local markets through customized local solutions. It also discusses the company's production processes, quality management systems, sales and marketing network, and focus on corporate social responsibility.
Nice neotech profile
Nice Neotech Medical Systems is a medical equipment company established in 1997 in India. It has over 4000 satisfied customers and 125 skilled employees. The company produces a range of neonatal intensive care unit products like incubators, radiant warmers, and respiratory humidifiers. Nice Neotech strives for innovation, high quality, and customer satisfaction in bringing affordable medical technology to the Indian and international markets.
Medical Packaging Experts
We at Buckell Plastic Co., Inc., understand the complex packaging requirements of the medical industry.
Hernia Repair Devices and Consumables Market is Expected to Reach $6.1 Billio...
Hernia Repair Devices and Consumables Market is Expected to Reach $6.1 Billio...Omkar Gaikwad (Digital Om)
Hernia Repair Devices and Consumables Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $6.1 Billion by 2020, registering a CAGR of 6.5% during the period 2014-2020. Consumables (mesh, staple and tacks) segment would continue to be the leading segment of the global hernia repair market in 2020, largely due to the augmentation in hernia cases, recurrence rate and emergence of advanced meshes.
View Detail Summary of this report: https://www.alliedmarketresearch.com/hernia-repair-devices-marketboston scientific 2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company's strong financial performance in 2005, with total revenue reaching $6.28 billion, a 12% increase over 2004. It summarizes key accomplishments across its business units, including maintaining the leading market share for drug-eluting stents. It also addresses the FDA's letter regarding quality compliance systems and the company's response to comprehensively address issues. Looking ahead, the report discusses strategic priorities like accelerating base business growth and expanding drug-eluting stent market share.
boston scientific2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company's strong financial performance in 2005, with total revenue reaching $6.28 billion, a 12% increase over 2004. It summarizes key accomplishments across its business units, including maintaining the leading market share for drug-eluting stents. It also addresses the FDA's letter regarding quality compliance systems and the company's response to comprehensively address issues. Looking ahead, it discusses strategic priorities like accelerating base business growth and expanding drug-eluting stent market share through new products.
boston scientific2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company's strong financial performance in 2005, with total revenue reaching $6.28 billion, a 12% increase over 2004. It summarizes key accomplishments across its business units, including maintaining the leading market share for drug-eluting stents. It also addresses the FDA's letter regarding quality compliance systems and the company's response to comprehensively address issues. Looking ahead, the report discusses strategic priorities like accelerating base business growth and expanding drug-eluting stent market share.
Baxter 2005 AR
This 2005 annual report discusses Baxter's financial performance and innovations. It highlights Baxter's leadership in developing therapies like kidney dialysis and blood component therapy over its 75-year history. In 2005, Baxter introduced many new products, saw strong sales of products like ADVATE for hemophilia, and expanded its contract manufacturing facilities. The report discusses Baxter's strategies for continued growth, including expanding in developing markets and pursuing acquisitions and alliances.
MEDTECH 2014 Closing Keynote
Chris Cleary, Vice President of Corporate Development, Medtronic presented at MEDTECH 2014 on Fulfilling the Mission: Medtronic Embraces Change to Respond to an Evolving Healthcare Landscape.
boston scientific2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company achieving $6.28 billion in revenue in 2005, a 12% increase over 2004, driven by market leadership in drug-eluting stents. It summarizes clinical trial results and new product approvals. It also notes the proposed acquisition of Guidant would make Boston Scientific a leader in cardiac rhythm management and expand its technology portfolio. The report discusses initiatives to address quality issues raised by the FDA and invest in growth areas like neuromodulation, drug-eluting stents, and peripheral interventions.
Auxein medical Corporate profile
In over 60 countries, patients, doctors and partners alike depend on Auxein Medical to move forward. Every orthopaedic implant that we manufacture is built according to the highest quality standards. We take special pride in our dedicated team of experts that makes sure we stay in line with the stringent norms set by ISO 13485 2003, CE and US FDA 510k – a feat few in the industry have achieved.
In just seven years since inception the distinguishable quality and value advantage delivered by our generic orthopaedic implants has earned us the credibility to afford a rapidly expanding customer base, opportunities to provide OEM services to leading names in the industry as well as the confidence of the medical community at large.
Upon a strong foundation of proven customer satisfaction we are now building a world of exciting possibilities in R&D, innovation, customisation and education.
Corporate Presentation
Established in 2013, DelCure is a growing pharmaceutical company that aims to provide affordable and high quality healthcare. It has expanded its product portfolio, distribution network, and recognition within the industry. DelCure focuses on pediatric and orthopedic medicine and emphasizes its commitment to doctors through initiatives like Honour Your Doctor. The company manufactures its products through strategic partnerships to maintain high quality standards.
DelCure Corporate
DelCure LifeSciences Ltd. (DLL) is a full scale pharmaceutical company with an aim to bring differentiated high quality products through international collaboration with innovator companies from the USA, Switzerland, and European countries. High quality products are assured from our manufacturing partner of high repute.
Vision:
“To become the most respected, uniquely positioned leading pharmaceutical company in the chosen areas or specialty verticals in India and abroad with distinct value based characteristics”.
Purpose, Culture and Value at DelCure LifeSciences:
At DelCure LifeSciences, we strongly believe in promoting the purpose of Happiness and creating the culture of Helpfulness for DLL family members and the society, with the learning from Mother Nature, promoting sustainability and augmenting life with growth. We firmly believe in value of Truthfulness.
The Visionary:
The company was envisioned by pharma veteran Mr. Prashant Kumar Pathak. An inspiring and visionary leader has approximately three decades of rich experience in pharmaceutical industry in Sales & Marketing, International Business, and Supply Chain Management & Operations. Mr. Pathak served as Chief Executive – Global Formulations with RPG Lifesciences and Senior Director – Sales & Marketing with Dr. Reddy’s Laboratories.
He has well-rounded experience of running business arms in APAC, Central & Latin American countries & Africa. During his professional career he has managed large number of in licensing assignments and brought new products to India and has been instrumental in collaborating with institutions of repute in the country and USA.
Has been guide & mentor to many successful industry leaders and therefore, has created a highly competent top management team in Delcure Lifesciences.
KMT,Pdf,Intro
KMT is a leading healthcare solutions provider in the MENA region founded in 1996 with the mission to continually improve healthcare and quality of life through innovative solutions. They have over 265 personnel across 11 specialized companies representing leading international manufacturers with a focus on endoscopy, interventional cardiology, dental implantology, and consumer healthcare. KMT has a presence in key markets like UAE, KSA, and Egypt and is the market leader in several areas of healthcare within the MENA region.
Mckubs 120208 web
- Jeff Campbell, EVP and CFO of McKesson, presented at the UBS Healthcare Conference on February 8, 2012.
- McKesson is well-positioned for growth through leading market positions, a focus on higher margin businesses, and linking their distribution and technology segments.
- Their diversified portfolio across providers, payers, and connectivity provides a platform for steady long-term growth.
This Is Ge Cb 0508
This document provides an overview of General Electric (GE) including its history, performance, innovations, capabilities, challenges, and businesses. Key points include:
- GE has a long history, being listed on the original Dow Jones Industrial Index in 1896 and paying dividends continuously since 1899.
- GE engages in innovation across multiple industries, with notable innovations including the light bulb, jet engine, CT scanner, and wind turbines.
- GE operates across over 100 countries with 300,000+ employees and manufacturing sites in over 40 countries.
- GE faces the challenge of accelerating organic revenue growth to meet targets of $10-12 billion annually.
This Is Ge Cb 0508
This document provides an overview of General Electric (GE) including its history, performance, innovations, capabilities, challenges, and businesses. Key points include:
- GE has a long history, being listed on the original Dow Jones Industrial Index in 1896 and paying dividends continuously since 1899.
- GE engages in innovation across multiple industries, with notable innovations including the light bulb, jet engine, CT scanner, and wind turbines.
- GE operates across over 100 countries with 300,000+ employees and manufacturing sites in over 40 countries. Its businesses include aviation, healthcare, energy, and media.
- GE aims to accelerate organic revenue growth and address sustainability through initiatives like Ecomagination.
mHealth Israel_Cleveland Clinic_Innovaiton_Tom Sudow_June 2015
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
Coval
Coval S.A.S. is a company that has specialized in vacuum handling solutions for 30 years. It focuses on offering outstanding products and services to clients in various industries such as food processing, packaging, plastics, automotive, and aeronautics. Coval constantly invests in modernizing equipment, training, open innovation, and rigorous organization to guarantee high quality, responsiveness, and flexibility for clients. It provides customized solutions that consider the constraints and needs of clients' processes. Coval's technical and sales teams specialize in different industries to provide quick answers tailored to each client's needs.
Milestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. (MLSS) is a leading
medical research and development company
that designs and patents innovative injection
technology. Milestone's computer controlled
systems make injections precise, efficient, and
virtually painless.
With
174 foreign patents and 19 US patents
issued Milestone Scientific is the leader in
modern injection technology.
Milestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. (MLSS) is a leading
medical research and development company
that designs and patents innovative injection
technology. Milestone's computer controlled
systems make injections precise, efficient, and
virtually painless.
With 174 foreign patents and 19 US patents
issued Milestone Scientific is the leader in
modern injection technology.
Key Success Factor in Manufacturing
The document summarizes literature on innovation and identifies critical success factors and problems in implementing innovation. It analyzes innovation problems faced by five manufacturing companies in Kuala Lumpur. Key success factors identified include top management support, appropriate skills and technology, and monitoring systems. Problems include human resistance to change and difficulty solving technical issues. The conclusion recommends that following identified success factors leads to more successful innovation implementation.
Diversey Care Overview
Sealed Air creates solutions that transform industries by combining ideas and expertise. It reimagines how businesses operate to create more sustainable and efficient solutions. Sealed Air focuses on delivering shared value for customers through purposeful innovation, partnerships, and building knowledge. It aims to create business-changing results.
2002 Merrill Lynch Healthcare Services Conference Presentation
This document summarizes McKesson Corporation's presentation at the 2002 Merrill Lynch Healthcare Services Conference. McKesson is the largest healthcare services company, with $46 billion in revenues. It has seen seven consecutive quarters of earnings per share growth above 30% across its pharmaceutical, medical-surgical, and information solutions business units. McKesson aims to continue delivering industry-leading solutions and margin expansion across its business units to create value for customers and shareholders.
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
More Related Content
Similar to Yale Coalition Project
boston scientific 2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company's strong financial performance in 2005, with total revenue reaching $6.28 billion, a 12% increase over 2004. It summarizes key accomplishments across its business units, including maintaining the leading market share for drug-eluting stents. It also addresses the FDA's letter regarding quality compliance systems and the company's response to comprehensively address issues. Looking ahead, the report discusses strategic priorities like accelerating base business growth and expanding drug-eluting stent market share.
boston scientific2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company's strong financial performance in 2005, with total revenue reaching $6.28 billion, a 12% increase over 2004. It summarizes key accomplishments across its business units, including maintaining the leading market share for drug-eluting stents. It also addresses the FDA's letter regarding quality compliance systems and the company's response to comprehensively address issues. Looking ahead, it discusses strategic priorities like accelerating base business growth and expanding drug-eluting stent market share through new products.
boston scientific2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company's strong financial performance in 2005, with total revenue reaching $6.28 billion, a 12% increase over 2004. It summarizes key accomplishments across its business units, including maintaining the leading market share for drug-eluting stents. It also addresses the FDA's letter regarding quality compliance systems and the company's response to comprehensively address issues. Looking ahead, the report discusses strategic priorities like accelerating base business growth and expanding drug-eluting stent market share.
Baxter 2005 AR
This 2005 annual report discusses Baxter's financial performance and innovations. It highlights Baxter's leadership in developing therapies like kidney dialysis and blood component therapy over its 75-year history. In 2005, Baxter introduced many new products, saw strong sales of products like ADVATE for hemophilia, and expanded its contract manufacturing facilities. The report discusses Baxter's strategies for continued growth, including expanding in developing markets and pursuing acquisitions and alliances.
MEDTECH 2014 Closing Keynote
Chris Cleary, Vice President of Corporate Development, Medtronic presented at MEDTECH 2014 on Fulfilling the Mission: Medtronic Embraces Change to Respond to an Evolving Healthcare Landscape.
boston scientific2005_annual
The document is Boston Scientific's 2005 Annual Report. It discusses the company achieving $6.28 billion in revenue in 2005, a 12% increase over 2004, driven by market leadership in drug-eluting stents. It summarizes clinical trial results and new product approvals. It also notes the proposed acquisition of Guidant would make Boston Scientific a leader in cardiac rhythm management and expand its technology portfolio. The report discusses initiatives to address quality issues raised by the FDA and invest in growth areas like neuromodulation, drug-eluting stents, and peripheral interventions.
Auxein medical Corporate profile
In over 60 countries, patients, doctors and partners alike depend on Auxein Medical to move forward. Every orthopaedic implant that we manufacture is built according to the highest quality standards. We take special pride in our dedicated team of experts that makes sure we stay in line with the stringent norms set by ISO 13485 2003, CE and US FDA 510k – a feat few in the industry have achieved.
In just seven years since inception the distinguishable quality and value advantage delivered by our generic orthopaedic implants has earned us the credibility to afford a rapidly expanding customer base, opportunities to provide OEM services to leading names in the industry as well as the confidence of the medical community at large.
Upon a strong foundation of proven customer satisfaction we are now building a world of exciting possibilities in R&D, innovation, customisation and education.
Corporate Presentation
Established in 2013, DelCure is a growing pharmaceutical company that aims to provide affordable and high quality healthcare. It has expanded its product portfolio, distribution network, and recognition within the industry. DelCure focuses on pediatric and orthopedic medicine and emphasizes its commitment to doctors through initiatives like Honour Your Doctor. The company manufactures its products through strategic partnerships to maintain high quality standards.
DelCure Corporate
DelCure LifeSciences Ltd. (DLL) is a full scale pharmaceutical company with an aim to bring differentiated high quality products through international collaboration with innovator companies from the USA, Switzerland, and European countries. High quality products are assured from our manufacturing partner of high repute.
Vision:
“To become the most respected, uniquely positioned leading pharmaceutical company in the chosen areas or specialty verticals in India and abroad with distinct value based characteristics”.
Purpose, Culture and Value at DelCure LifeSciences:
At DelCure LifeSciences, we strongly believe in promoting the purpose of Happiness and creating the culture of Helpfulness for DLL family members and the society, with the learning from Mother Nature, promoting sustainability and augmenting life with growth. We firmly believe in value of Truthfulness.
The Visionary:
The company was envisioned by pharma veteran Mr. Prashant Kumar Pathak. An inspiring and visionary leader has approximately three decades of rich experience in pharmaceutical industry in Sales & Marketing, International Business, and Supply Chain Management & Operations. Mr. Pathak served as Chief Executive – Global Formulations with RPG Lifesciences and Senior Director – Sales & Marketing with Dr. Reddy’s Laboratories.
He has well-rounded experience of running business arms in APAC, Central & Latin American countries & Africa. During his professional career he has managed large number of in licensing assignments and brought new products to India and has been instrumental in collaborating with institutions of repute in the country and USA.
Has been guide & mentor to many successful industry leaders and therefore, has created a highly competent top management team in Delcure Lifesciences.
KMT,Pdf,Intro
KMT is a leading healthcare solutions provider in the MENA region founded in 1996 with the mission to continually improve healthcare and quality of life through innovative solutions. They have over 265 personnel across 11 specialized companies representing leading international manufacturers with a focus on endoscopy, interventional cardiology, dental implantology, and consumer healthcare. KMT has a presence in key markets like UAE, KSA, and Egypt and is the market leader in several areas of healthcare within the MENA region.
Mckubs 120208 web
- Jeff Campbell, EVP and CFO of McKesson, presented at the UBS Healthcare Conference on February 8, 2012.
- McKesson is well-positioned for growth through leading market positions, a focus on higher margin businesses, and linking their distribution and technology segments.
- Their diversified portfolio across providers, payers, and connectivity provides a platform for steady long-term growth.
This Is Ge Cb 0508
This document provides an overview of General Electric (GE) including its history, performance, innovations, capabilities, challenges, and businesses. Key points include:
- GE has a long history, being listed on the original Dow Jones Industrial Index in 1896 and paying dividends continuously since 1899.
- GE engages in innovation across multiple industries, with notable innovations including the light bulb, jet engine, CT scanner, and wind turbines.
- GE operates across over 100 countries with 300,000+ employees and manufacturing sites in over 40 countries.
- GE faces the challenge of accelerating organic revenue growth to meet targets of $10-12 billion annually.
This Is Ge Cb 0508
This document provides an overview of General Electric (GE) including its history, performance, innovations, capabilities, challenges, and businesses. Key points include:
- GE has a long history, being listed on the original Dow Jones Industrial Index in 1896 and paying dividends continuously since 1899.
- GE engages in innovation across multiple industries, with notable innovations including the light bulb, jet engine, CT scanner, and wind turbines.
- GE operates across over 100 countries with 300,000+ employees and manufacturing sites in over 40 countries. Its businesses include aviation, healthcare, energy, and media.
- GE aims to accelerate organic revenue growth and address sustainability through initiatives like Ecomagination.
mHealth Israel_Cleveland Clinic_Innovaiton_Tom Sudow_June 2015
Presentation at mHealth Israel Investors Summit by Tom Sudow, Head of Business Development: "Successful Commercialization – The Cleveland Clinic Story". The mission is to promote Innovation via Commercialization by bringing new innovations into widespread clinical practice, protecting the intellectual property underlying the innovations, optimizing the value returned for those innovations, and growing the regional economy.
Coval
Coval S.A.S. is a company that has specialized in vacuum handling solutions for 30 years. It focuses on offering outstanding products and services to clients in various industries such as food processing, packaging, plastics, automotive, and aeronautics. Coval constantly invests in modernizing equipment, training, open innovation, and rigorous organization to guarantee high quality, responsiveness, and flexibility for clients. It provides customized solutions that consider the constraints and needs of clients' processes. Coval's technical and sales teams specialize in different industries to provide quick answers tailored to each client's needs.
Milestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. (MLSS) is a leading
medical research and development company
that designs and patents innovative injection
technology. Milestone's computer controlled
systems make injections precise, efficient, and
virtually painless.
With
174 foreign patents and 19 US patents
issued Milestone Scientific is the leader in
modern injection technology.
Milestone Scientific Inc. Investor Presentation
Milestone Scientific Inc. (MLSS) is a leading
medical research and development company
that designs and patents innovative injection
technology. Milestone's computer controlled
systems make injections precise, efficient, and
virtually painless.
With 174 foreign patents and 19 US patents
issued Milestone Scientific is the leader in
modern injection technology.
Key Success Factor in Manufacturing
The document summarizes literature on innovation and identifies critical success factors and problems in implementing innovation. It analyzes innovation problems faced by five manufacturing companies in Kuala Lumpur. Key success factors identified include top management support, appropriate skills and technology, and monitoring systems. Problems include human resistance to change and difficulty solving technical issues. The conclusion recommends that following identified success factors leads to more successful innovation implementation.
Diversey Care Overview
Sealed Air creates solutions that transform industries by combining ideas and expertise. It reimagines how businesses operate to create more sustainable and efficient solutions. Sealed Air focuses on delivering shared value for customers through purposeful innovation, partnerships, and building knowledge. It aims to create business-changing results.
2002 Merrill Lynch Healthcare Services Conference Presentation
This document summarizes McKesson Corporation's presentation at the 2002 Merrill Lynch Healthcare Services Conference. McKesson is the largest healthcare services company, with $46 billion in revenues. It has seen seven consecutive quarters of earnings per share growth above 30% across its pharmaceutical, medical-surgical, and information solutions business units. McKesson aims to continue delivering industry-leading solutions and margin expansion across its business units to create value for customers and shareholders.
Similar to Yale Coalition Project (20)
mHealth Israel_Cleveland Clinic_Innovaiton_Tom Sudow_June 2015
mHealth Israel_Cleveland Clinic_Innovaiton_Tom Sudow_June 2015
2002 Merrill Lynch Healthcare Services Conference Presentation
2002 Merrill Lynch Healthcare Services Conference Presentation
Recently uploaded
Acute Gout Care & Urate Lowering Therapy .pdf
In this document , the management of acute gout attacks and a description of urate lowering therapy is mentioned.
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
low birth weight presentation. Low birth weight (LBW) infant is defined as the one whose birth weight is less than 2500g irrespective of their gestational age. Premature birth and low birth weight(LBW) is still a serious problem in newborn. Causing high morbidity and mortality rate worldwide. The nursing care provide to low birth weight babies is crucial in promoting their overall health and development. Through careful assessment, diagnosis,, planning, and evaluation plays a vital role in ensuring these vulnerable infants receive the specialize care they need. In India every third of the infant weight less than 2500g.
Birth period, socioeconomical status, nutritional and intrauterine environment are the factors influencing low birth weight
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Fallopian tube blockage may cause female infertility. For treatment, herbal medicine Fuyan Pill can be a solution.
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff offers comprehensive travel health services, including vaccinations, travel advice, and preventive care for international travelers. Our expert team ensures you are well-prepared and protected for your journey, providing personalized consultations tailored to your destination. Conveniently located in Cardiff, we help you travel with confidence and peace of mind. Visit us: www.nxhealthcare.co.uk
10 Benefits an EPCR Software should Bring to EMS Organizations
The benefits of an ePCR solution should extend to the whole EMS organization, not just certain groups of people or certain departments. It should provide more than just a form for entering and a database for storing information. It should also include a workflow of how information is communicated, used and stored across the entire organization.
The Nervous and Chemical Regulation of Respiration
These lecture slides, by Dr Sidra Arshad, offer a simplified look into the mechanisms involved in the regulation of respiration:
Learning objectives:
1. Describe the organisation of respiratory center
2. Describe the nervous control of inspiration and respiratory rhythm
3. Describe the functions of the dorsal and respiratory groups of neurons
4. Describe the influences of the Pneumotaxic and Apneustic centers
5. Explain the role of Hering-Breur inflation reflex in regulation of inspiration
6. Explain the role of central chemoreceptors in regulation of respiration
7. Explain the role of peripheral chemoreceptors in regulation of respiration
8. Explain the regulation of respiration during exercise
9. Integrate the respiratory regulatory mechanisms
10. Describe the Cheyne-Stokes breathing
Study Resources:
1. Chapter 42, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 36, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 13, Human Physiology by Lauralee Sherwood, 9th edition
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...Kosmoderma Academy Of Aesthetic Medicine
Kosmoderma Academy, a leading institution in the field of dermatology and aesthetics, offers comprehensive courses in cosmetology and trichology. Our specialized courses on PRP (Hair), DR+Growth Factor, GFC, and Qr678 are designed to equip practitioners with advanced skills and knowledge to excel in hair restoration and growth treatments.
Pollen and Fungal allergy: aeroallergy.pdf
Pollen and Fungal allergy: aeroallergy.pdfChulalongkorn Allergy and Clinical Immunology Research Group
Pollen and Fungal allergy
Presented by Chaloemchai Chumsaengchotsakul, MD.
June 14, 2024Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
learning occurs when a stimulus (unconditioned stimulus) eliciting a response (unconditioned response) • is paired with another stimulus (conditioned stimulus)
Cervical Disc Arthroplasty ORSI 2024.pptx
Indication and installation of a mobile cervical disc prosthesis. Benefits of the PRODISC C VIVO mobile disc prosthesis (Centinel Spine)
Cell Therapy Expansion and Challenges in Autoimmune Disease
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...PVI, PeerView Institute for Medical Education
Co-Chairs, Val J. Lowe, MD, and Cyrus A. Raji, MD, PhD, prepared useful Practice Aids pertaining to Alzheimer’s disease for this CME/AAPA activity titled “Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neuroradiology in Diagnosis and Treatment.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3PvVY25. CME/AAPA credit will be available until June 28, 2025.CLEAR ALIGNER THERAPY IN ORTHODONTICS .pptx
Dr. ZANAB FARHEEN FAYAZ ,MDS(ORTHODONTICS & DENTOFACIAL ORTHOPEDICS ).
Know the difference between Endodontics and Orthodontics.
Your smile is beautiful.
Let’s be honest. Maintaining that beautiful smile is not an easy task. It is more than brushing and flossing. Sometimes, you might encounter dental issues that need special dental care. These issues can range anywhere from misalignment of the jaw to pain in the root of teeth.
vonoprazan A novel drug for GERD presentation
Vonoprazan, a new potassium acid channel blocker used in the conditions of GERD and gastric ulcer, duodenal ulcer ....
Recently uploaded (20)
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
LOW BIRTH WEIGHT. PRETERM BABIES OR SMALL FOR DATES BABIES
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Demystifying Fallopian Tube Blockage- Grading the Differences and Implication...
Travel Clinic Cardiff: Health Advice for International Travelers
Travel Clinic Cardiff: Health Advice for International Travelers
10 Benefits an EPCR Software should Bring to EMS Organizations
10 Benefits an EPCR Software should Bring to EMS Organizations
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Cosmetology and Trichology Courses at Kosmoderma Academy PRP (Hair), DR Growt...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Lecture 6 -- Memory 2015.pptlearning occurs when a stimulus (unconditioned st...
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Tele Optometry (kunj'sppt) / Basics of tele optometry.
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Alzheimer’s Disease Case Conference: Gearing Up for the Expanding Role of Neu...
Know the difference between Endodontics and Orthodontics.
Know the difference between Endodontics and Orthodontics.
Yale Coalition Project
- 1. Providing Medical Miracles Through Innovative Surgical Products Wound Closure Hernia Repair Surgical Device Bio Surgery
- 2. Mission “Create and deliver innovative healthcare solutions, developed in ethical collaborationwith medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders.” Foundational Pillars High Performance Organization Globalization Customer Focus Innovation
- 3. Focus on Improving Healthcare High Organization Globalization
- 4. 2007 LEADERSHIP PHASE 1998 2001 2002 PARITY PHASE 1991 1991 Tyco Acquires Davis & Geck Merges Suture Business 1995 1970 1909 PIONEERING PHASE US Surgical enters Suture Market 1985 Founding of Davis & Geck
- 5. LEADERSHIP PHASE NUPACK™ PACKAGING SE NEEDLE UPGRADE CAPROSYN™ DYED CAPROSYN™ SURGIPRO™ II ENHANCED SURGIPRO™ II DERMAX™ 2005 2001 2002 2003 2006 2007 OPHTHALMIC NEEDLES INDERMIL® PROTECT●POINT™ NUCOAT™ NEEDLE LINE EXPANSION NUCOAT™ ON CV NEEDLES IMPROVED MAXON™
- 6. Prestigious Collaboration 6of these 14 hospitals are committed Covidien Wound Closure customers All distinguished “America’s Best Hospitals” 2010-2011 Honor Roll 1. Johns Hopkins Hospital, Baltimore Mayo Clinic, Rochester, MN Massachusetts General Hospital, Boston Cleveland Clinic Ronald Reagan UCLA Medical Center, Los Angeles 6. New York-Presbyterian University Hospital of Columbia and Cornell University of California, San Francisco Medical Center Barnes Jewish Hospital/Washington University, St. Louis Hospital of the University of Pennsylvania, Philadelphia Duke University Medical Center, Durham, N.C. 11.Brigham and Women's Hospital, Boston 12.University of Washington Medical Center, Seattle 13.UPMC - Univ of Pittsburgh Medical Center University of Michigan Hospitals and Health Centers, Ann Arbor U.S. News & World Report Best Health 2010-2011
- 7. Syneture Wound Closure Products
- 10. V-Loc 90 & 180 Absorbable Wound Closure Device
- 12. Components to a Successful Conversion Phase I – Pre Clinical Phase II - Clinical Phase III - Logistics Phase IV – Fine Tuning
- 13. OnTrack™ Step by Step Transition Plan
- 14. Customized Validation Plan Sample
Editor's Notes
- Surgipro IIPEG additive- better knot run down, less tissue dragExtrusion process- more consistent suture, reduces “surprise” breakageResin- MaxonNeedlesSurgalloy
- CaprosynOnly short-term monofilament on the marker2 week wound support, absorbs in 56 daysGreat substitute for gut (synthetic, monofilament, handling)NovafilNon absorbableElastic- accommodates edema Hydrophobic- easily removable Polybutester composition- does not frayNeedlesSurgalloy- great strength NuCoat- silicone coating that provides durability pass after pass and lowered initial penetration force Variety of Needle Tip Geometries- IndermilTopical adhesive that requires only one coatRe-capable lid; allows for multiple use on one patient
- Secure. Fast. Effective.
- Transition Slide (from product to conversion process)People: Reps and managerscomplete a rigorous training course, highly skilled and able to explain products and processes thoroughly and effectivelyProducts: High quality and and dependable products (mention developments and changes made to products, as was discussed earlier in presentation) Process: Propriety transition process
- Three core themes-explain what each theme entailsProprietary transition process which focuses on three core themes aligned to customers:
- Use this as handout.Example of a customized validation plan, emphasize that each plan is tailored to fit needs of customer